NewAmsterdam Pharma N.V.
24.14
0.47 (1.99%)
At close: Jan 15, 2025, 10:16 AM

NewAmsterdam Pharma N.V. Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for NAMS stock have an median target of 36.5, with a low estimate of 30 and a high estimate of 48. The median target predicts an increase of 51.20% from the current stock price of 24.14.

Analyst Consensus: Buy
Target Low Average Median High
Price $30 $38.17 $36.5 $48
Change 24.28% 58.12% 51.20% 98.84%

AI Analyst Report

HC Wainwright & Co. maintains a Buy rating on NewA... Unlock content with Pro Subscription

Updated Jan 14, 2025

Rating Jul 24Aug 24Sep 24Nov 24Dec 24Jan 25
Strong Buy 000000
Buy 112331
Hold 000000
Sell 000000
Strong Sell 000000
Total 1 1 2 3 3 1

Financial Forecast this Year

Revenue This Year
33.77M
from 12.76M
Increased by 164.6%
Revenue Next Year
9.75M
from 33.77M
Increased by -71.1%
EPS This Year
-1.97
from -2.15
Increased by 8.4%
EPS Next Year
-1.78
from -1.97
Increased by 9.6%